Tina Davis

2.4k total citations · 1 hit paper
20 papers, 1.6k citations indexed

About

Tina Davis is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Tina Davis has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Tina Davis's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Tina Davis is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Research and Treatments (3 papers) and Protein Degradation and Inhibitors (3 papers). Tina Davis collaborates with scholars based in United States, United Kingdom and China. Tina Davis's co-authors include Andrew L. Kung, James E. Bradner, Gregory L. Verdine, Stephen C. Blacklow, Jon C. Aster, Cristina Del Bianco, Melanie Cornejo, D. Gary Gilliland, Raymond E. Moellering and John Chae and has published in prestigious journals such as Nature, Blood and Gastroenterology.

In The Last Decade

Tina Davis

20 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Direct inhibition of the NOTCH transcription factor complex

2009 619 citations Raymond E. Moellering, Melanie Cornejo et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tina Davis United States	11	1.0k	269	215	198	160	20	1.6k
Maribel Parra Spain	23	1.6k 1.6×	112 0.4×	354 1.6×	48 0.2×	297 1.9×	34	2.1k
Lina Dagnino Canada	30	1.6k 1.6×	35 0.1×	532 2.5×	151 0.8×	227 1.4×	89	2.6k
Jerry DiSalvo United States	17	1.2k 1.2×	60 0.2×	219 1.0×	99 0.5×	183 1.1×	22	1.7k
Pnina Bashkin Israel	13	1.4k 1.4×	121 0.4×	146 0.7×	27 0.1×	139 0.9×	18	2.0k
Annapaola Andolfo Italy	22	716 0.7×	156 0.6×	220 1.0×	17 0.1×	134 0.8×	49	1.5k
Miki Nakamura Japan	22	1.2k 1.2×	44 0.2×	160 0.7×	18 0.1×	133 0.8×	87	1.7k
Małgorzata Zakrzewska Poland	25	1.2k 1.2×	33 0.1×	208 1.0×	36 0.2×	190 1.2×	71	1.5k
Kohji Kasahara Japan	22	1.1k 1.1×	210 0.8×	107 0.5×	13 0.1×	173 1.1×	60	1.6k
Giles O. Cory United Kingdom	14	511 0.5×	103 0.4×	149 0.7×	33 0.2×	387 2.4×	19	1.4k
Daniel R. Croft United Kingdom	21	1.0k 1.0×	38 0.1×	443 2.1×	34 0.2×	175 1.1×	30	1.8k

Countries citing papers authored by Tina Davis

Since Specialization

Citations

This map shows the geographic impact of Tina Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tina Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tina Davis more than expected).

Fields of papers citing papers by Tina Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tina Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tina Davis. The network helps show where Tina Davis may publish in the future.

Co-authorship network of co-authors of Tina Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Tina Davis. A scholar is included among the top collaborators of Tina Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tina Davis. Tina Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tohmé, Mira, Tina Davis, Hadia Lemar, et al.. (2022). 902 NKX019, an off-the-shelf CD19 CAR-NK cell, mediates improved anti-tumor activity and persistence in combination with CD20-directed therapeutic mAbs. Regular and Young Investigator Award Abstracts. A940–A940. 3 indexed citations

Youngblood, Bradford A., Tina Davis, Julia Schanin, et al.. (2020). Tu1251 MAST CELLS ARE SIGNIFICANTLY ACTIVATED IN PATIENTS WITH ULCERATIVE COLITIS AND ARE INHIBITED BY AN ANTI-SIGLEC-8 ANTIBODY, ANTOLIMAB (AK002). Gastroenterology. 158(6). S–1033. 1 indexed citations

Morisot, Nadège, Tina Davis, Kyle Hansen, et al.. (2020). 127 Preclinical evaluation of NKX019, a CD19-targeting CAR NK Cell. Regular and Young Investigator Award Abstracts. A78–A78. 5 indexed citations

Moan, Natacha Le, Sarah Ng, Tina Davis, et al.. (2018). Abstract 4726A: The oxygen carrier omx restores antitumor immunity and cures tumors as a single agent or in combination with checkpoint inhibitors in an intracranial glioblastoma mouse model. Cancer Research. 78(13_Supplement). 4726A–4726A. 2 indexed citations

Moan, Natacha Le, et al.. (2017). Abstract 4686: Omx a hypoxia modulator reverses the immunosuppressive glioblastoma microenvironment by stimulating T cell infiltration and activation that results in increased number of long-term survivors. Cancer Research. 77(13_Supplement). 4686–4686. 4 indexed citations

Stubbs, Matthew C., Won-Il Kim, Tina Davis, et al.. (2015). Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL. Clinical Cancer Research. 21(10). 2348–2358. 59 indexed citations

Krtolica, Ana, Natacha Le Moan, Tina Davis, et al.. (2015). Abstract 3003: OMX-4.80P, a novel H-NOX oxygen carrier that oxygenates hypoxic tumors in multiple tumor models and canine cancer patients, downregulates HIF-1 pathway and increases response to radiation therapy leading to cures. Cancer Research. 75(15_Supplement). 3003–3003. 1 indexed citations

Xu, Hui, Tao Zhang, Gene Chi Wai Man, et al.. (2013). Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis. 16(3). 541–551. 42 indexed citations

Xu, Hui, Christian M. Becker, Wai Ting Lui, et al.. (2011). Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo. Fertility and Sterility. 96(4). 1021–1028.e1. 80 indexed citations

10.

Beier, Kevin T., Tina Davis, Jen‐Chieh Tseng, et al.. (2011). A Class of Human Proteins that Deliver Functional Proteins into Mammalian Cells In Vitro and In Vivo. Chemistry & Biology. 18(7). 833–838. 90 indexed citations

11.

Stubbs, Matthew C., Won-Il Kim, Tina Davis, et al.. (2010). Selective Inhibition of HDAC1 and HDAC2 Is a Potential Therapeutic Option for B-All. Blood. 116(21). 2900–2900. 3 indexed citations

12.

Hahn, Cynthia K., Jacob E. Berchuck, Kenneth N. Ross, et al.. (2009). Proteomic and Genetic Approaches Identify Syk as an AML Target. Cancer Cell. 16(4). 281–294. 120 indexed citations

13.

Kimbrel, Erin A., Tina Davis, James E. Bradner, & Andrew L. Kung. (2009). In Vivo Pharmacodynamic Imaging of Proteasome Inhibition. Molecular Imaging. 8(3). 140–7. 42 indexed citations

14.

Moellering, Raymond E., Melanie Cornejo, Tina Davis, et al.. (2009). Direct inhibition of the NOTCH transcription factor complex. Nature. 462(7270). 182–188. 619 indexed citations breakdown →

15.

Bernt, Kathrin M., Jörg Faber, Tina Davis, Andrew L. Kung, & Scott A. Armstrong. (2009). DOT1L and Histone H3 Lysine79 Methylation as a Therapeutic Target in Mixed Lineage Leukemia.. Blood. 114(22). 212–212. 4 indexed citations

16.

Kimbrel, Erin A., Madeleine E. Lemieux, Xiaobo Xia, et al.. (2009). Systematic in vivo structure-function analysis of p300 in hematopoiesis. Blood. 114(23). 4804–4812. 28 indexed citations

17.

Faber, Joerg, Andrei V. Krivtsov, Matthew C. Stubbs, et al.. (2008). HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood. 113(11). 2375–2385. 234 indexed citations

18.

Merchant, Thomas E., et al.. (2007). A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiation Oncology. 2(1). 45–45. 44 indexed citations

19.

Chae, John, et al.. (1998). Neuromuscular Stimulation for Upper Extremity Motor and Functional Recovery in Acute Hemiplegia. Stroke. 29(5). 975–979. 227 indexed citations

20.

Davis, Tina, et al.. (1993). The gene therapy of cancer: transgenic immunotherapy.. PubMed. 30(4 Suppl 4). 119–28; discussion 129. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact